Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants

Clinical and Experimental Immunology

Volumn 132, Issue 2, 2003, Pages 345-351

  Kwekkeboom, J ^a   Kuijpers, M A ^a   Bruyneel, B ^a   Mancham, S ^a   De Baar Heesakkers, E ^a   Ijzermans, J N M ^a   Bouma, G J ^a   Zondervan, P E ^a   Tilanus, H W ^a   Metselaar, H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute rejection; CD80; CD86; Kupffer cells; Liver transplantation

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CD86 ANTIGEN; CHLORDANE; MESSENGER RNA;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KUPFFER CELL; LIVER; LIVER GRAFT; LIVER TRANSPLANTATION; MACROPHAGE; MEDICAL INFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SURGICAL TECHNIQUE;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CADAVER; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KUPFFER CELLS; LIVER TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037879294     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02129.x     Document Type: Article

References (32)

1. Markus BH, Duquesnoy RJ, Gordon RD et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46:372-7.
2. Donaldson P, Underhill J, Doherty D et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: 'the dualistic effect'. Hepatology 1993; 17:1008-15.
3. Nikaein A, Backman L, Jennings L et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994; 58:786-92.
4. Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection, incidence, risk factors, and impact on outcome. Hepatology 1998; 28:638-45.
5. Bathgate AJ, Pravica V, Perrey C et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000; 69:1514-7.
6. Warle MC, Farhan A, Metselaar HJ et al. Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transplant 2002; 8:603-11.
7. Sayegh MH, Turka LA. The role of T cell co-stimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338:1813-21.
8. Tu Y, Rehman A, Flye MW. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival. Transplant Proc 1997; 29:1036-7.
9. Van Gool SW, de Boer M, Ceuppens JL. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J Immunol 1993; 150:3254-63.
10. Guinan EC, Gribben JG, Boussiotis VA, Freeman G J, Nadler LM. Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84:3261-82.
11. Reiser H, Stadecker MJ. Co-stimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996; 335:1369-77.
12. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180:1849-60.
13. Lohse AW, Knolle PA, Bilo K et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996; 110:1175-81.
14. Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol 1999; 154:1711-20.
15. Burgio VL, Ballardini G, Artini M, Caratozzolo M, Bianchi FB, Levrero M. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 1998; 27:1600-6.
16. Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65:1533-42.
17. van tier Hoeven JA, Ploeg RJ, Postema F et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation 1999; 68:1884-90.
18. van Goor H, Rosman C, Grond J, Kooi K, Wubbels GH, Bleichrodt RP. Translocation of bacteria and endotoxin in organ donors. Arch Surg 1994; 129:1063-6.
19. Arai M, Peng XX, Currin RT, Thurman RG, Lemasters JJ. Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E2 derived from Kupffer cells. Transplantation 1999; 68:440-5.
20. Caries J, Fawaz R, Hamoudi NE, Neaud V, Balabaud C, Bioulac-Sage P. Preservation of human liver grafts in UW solution. Ultrastructural evidence for endothelial and Kupffer cell activation during cold ischemia and after ischemia-reperfusion. Liver 1994: 14:50-6.
21. Lemasters JJ, Bunzendahl H, Thurman RG. Reperfusion injury to donor livers stored for transplantation. Liver Transpl Surg 1995; 1:124-38.
22. Meijerink J, Mandigers C, van de Locht L, Tonnissen E, Goodsaid F, Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative realtime PCR. J Mol Diagn 2001; 3:55-61.
23. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 158:1989-93.
24. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001; 2:58-63.
25. van der Hoeven JA, Ter Horst GJ, Molema G et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000; 232:804-13.
26. Amado JA, Lopez-Espadas F, Vazquez-Barquero A et al. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism 1995; 44:812-6.
27. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43:852-4.
28. Chambers CA, Allison TP. Co-stimulation in T cell responses. Curr Opin Immunol 1997; 9:396-404.
29. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 co-stimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100:1199-203.
30. Crispe IN. Hepatic T cells and liver tolerance. Nature Immunol Rev 2003; 3:51-61.
31. Le Bouteiller P, Barakonyi A, Giustiniani J et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 2002; 99:16963-8.
32. Van Hoffen E, Van Wichen DF, Leemans JC et al. T cell apoptosis in human heart allografts, association with lack of co-stimulation? Am J Pathol 1998; 153:1813-24.